All Journal Guides

Journal Guide

Hepatology Impact Factor 15.8: Publishing Guide

AASLD's flagship journal: definitive liver research from bench to bedside

15.8

Impact Factor (2024)

~15%

Acceptance Rate

~30 days

Time to First Decision

What Hepatology Publishes

Hepatology is THE liver journal. If you study any aspect of liver biology or disease, this is your target venue. AASLD's flagship publication covers everything from basic hepatocyte biology to clinical hepatology, with particular strength in NAFLD/NASH, viral hepatitis, and hepatocellular carcinoma.

  • Basic liver biology including hepatocyte function, liver development, and regeneration
  • Liver disease pathophysiology from molecular to clinical levels
  • NAFLD/NASH research including pathogenesis, biomarkers, and therapeutics
  • Viral hepatitis studies covering HBV, HCV, and emerging viral threats
  • Hepatocellular carcinoma research from basic mechanisms to clinical trials
  • Liver transplantation research including immunology and outcomes

Editor Insight

Hepatology serves the liver community specifically. We want research that advances understanding of liver biology or improves care for patients with liver disease. Generic studies that happen to use liver models aren't enough - we need liver-focused insight.

What Hepatology Editors Look For

Liver-specific expertise and insight

Generic studies applied to liver aren't enough. Hepatology wants research that deepens understanding of liver-specific biology, pathology, or clinical management.

Translational bridge from bench to clinic

Whether starting with basic biology or clinical observation, connect your findings to patient care. How does this change our understanding of liver disease?

Methodological rigor in liver research

Liver research has unique technical challenges. Proper controls, appropriate models, and validation across systems are essential.

Clinical relevance to hepatologists

Will a practicing hepatologist change how they think about or treat liver disease? Make the clinical implications clear and specific.

Innovation in liver-specific approaches

New models, new techniques, new ways of studying liver function. The liver field values methodological advances that enable new discoveries.

Thorough experimental validation

Multiple models, orthogonal approaches, and human relevance. If you're making claims about liver biology, prove them convincingly.

Why Papers Get Rejected

These patterns appear repeatedly in manuscripts that don't make it past Hepatology's editorial review:

Generic inflammation studies applied to liver

Showing that pathway X is involved in liver inflammation without liver-specific insight doesn't advance the field. What's unique about the liver context?

Single mouse strain without validation

Liver phenotypes can be strain-specific. Validation across multiple models or in human samples strengthens claims dramatically.

Biomarker papers without mechanistic insight

Finding that protein X correlates with liver fibrosis isn't enough. Why is it elevated? What does it tell us about disease mechanism?

Overinterpreting in vitro hepatocyte data

Primary hepatocytes lose function rapidly in culture. Cell line data needs validation in more physiological systems.

Missing human disease relevance

Beautiful mouse studies that don't connect to human liver disease feel incomplete. Address clinical relevance explicitly.

Inadequate controls for liver-specific factors

Liver has unique metabolism, blood flow, and cellular composition. Controls must account for these factors.

Does your manuscript avoid these patterns?

The quick diagnostic reads your full manuscript against Hepatology's criteria and flags the specific issues most likely to cause rejection.

Run Free Readiness Scan →

Insider Tips from Hepatology Authors

NAFLD/NASH is the hottest area

With the obesity epidemic, NAFLD/NASH research gets extra attention. If your work touches this area, emphasize it. Multiple drugs are in development.

Journal of Hepatology is your main competitor

Both are top liver journals. Know what JHep has published recently in your area. Editors expect you to differentiate your contribution.

AASLD meeting connections help but aren't required

Work presented at The Liver Meeting gets visibility, but quality matters more than politics. International submissions are welcome.

Liver organoid models are increasingly valued

Patient-derived liver organoids and liver-on-chip systems are transforming the field. These models can strengthen basic studies.

Viral hepatitis remains important

Despite HCV cures, viral hepatitis research remains relevant. HBV functional cure, HCV resistance, and new viral threats are active areas.

Single-cell approaches are hot

The liver's cellular heterogeneity is being mapped in disease. Single-cell RNA-seq, spatial transcriptomics, and cell-type-specific studies are valued.

Clinical cohort validation strengthens basic work

If you can validate mouse findings in patient liver biopsies or plasma samples, do it. This elevates basic research to clinical relevance.

Liver transplant research has a dedicated readership

Transplant immunology, organ preservation, and outcomes research serve an important clinical community within hepatology.

The Hepatology Submission Process

1

Presubmission inquiry (optional)

Response within 1-2 weeks

Brief pitch for unusual study types or borderline topics. Most submissions go straight to full submission.

2

Full submission

Initial decision ~30 days

Complete manuscript emphasizing liver-specific insights and clinical relevance. Strong figures showing key liver-related findings.

3

Editorial triage

~2-3 weeks

Assessment of liver specificity, methodological rigor, and clinical relevance. Desk rejection ~50%.

4

Peer review

4-6 weeks

2-3 reviewers with liver expertise. Focus on technical rigor and advancement of liver science.

5

Revision

2-4 months typical

Revision requests often include additional validation experiments or human data analysis.

Hepatology by the Numbers

2024 Impact Factor(Clarivate JCR)12.9
Submissions per year~2,200
Acceptance rate~15%
Desk rejection rate~50%
Time to first decision30 days median
Monthly publication12 issues/year
AASLD membership4,000+ liver specialists worldwide

Before you submit

Hepatology accepts a small fraction of submissions. Make your attempt count.

The pre-submission diagnostic runs a live literature search, scores your manuscript section by section, and gives you a prioritized fix list calibrated to Hepatology. ~30 minutes.

Article Types

Original Research

No strict limit; thorough studies expected

Full research reports advancing liver science

Brief Communication

Shorter format with key findings

Focused reports of exceptional liver-related findings

Clinical Research

Variable based on study scope

Patient studies with implications for hepatology practice

Review

By invitation or proposal

In-depth reviews of liver topics

Landmark Hepatology Papers

Papers that defined fields and changed science:

  • Discovery of hepatitis C virus (Choo et al., 1989, Nobel Prize 2020)
  • MELD score for liver allocation (Kamath et al., 2001)
  • First description of NAFLD histological scoring system (Kleiner et al., 2005)
  • Discovery of hepatic stellate cells in fibrosis (Friedman et al., 1985)
  • PNPLA3 genetic variant in NAFLD susceptibility (Romeo et al., 2008)

Preparing a Hepatology Submission?

Get pre-submission feedback from reviewers who've published in Hepatology and know exactly what editors look for.

Run Free Readiness Scan

Need expert depth? Human review from $1,000

NDA-protected
Confidential

Primary Fields

HepatologyNAFLD/NASHViral HepatitisLiver CancerLiver TransplantationLiver FibrosisLiver MetabolismLiver Immunology